CLINICAL_TRIALS
trial_result
· 2023-07-03
Clinical Trial Update: Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis [Phase 2]
Summary
Phase 2 trial assessing safety and efficacy of ARQ-154 Foam for seborrheic dermatitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Arcutis Biotherapeutics, Inc. | Conditions: Seborrheic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-07-03